Cargando…

Clinical Outcomes after Intravenous Alteplase in Elderly Patients with Acute Ischaemic Stroke: A Retrospective Analysis of Patients Treated at a Tertiary Neurology Centre in England from 2013 to 2018

Intravenous thrombolysis with alteplase within 4.5 hours from symptom onset is a well-established treatment of acute ischaemic stroke (AIS). The aim was to compare alteplase for AIS between patients aged >80 and ≤80 years in our registry data, from 2013 to 2018. Mechanical thrombectomy cases were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xuya, Nash, Phillip, Alakbarzade, Vafa, Clarke, Brian, Pereira, Anthony C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572621/ https://www.ncbi.nlm.nih.gov/pubmed/34754411 http://dx.doi.org/10.1155/2021/3738017

Ejemplares similares

Normal Appearing Ischaemic Brain Tissue on CT and Outcome After Intravenous Alteplase
por: Mair, Grant, et al.
Publicado: (2022)

Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
por: Nie, Ximing, et al.
Publicado: (2021)

Effect of intravenous thrombolysis with alteplase on clinical efficacy, inflammatory factors, and neurological function in patients with acute cerebral infarction
por: Wang, Jinhua, et al.
Publicado: (2021)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
por: Gao, Lilin, et al.
Publicado: (2022)

Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke
por: Wu, Simiao, et al.
Publicado: (2020)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms
por: Urrutia, Victor C., et al.
Publicado: (2018)

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
por: Emberson, Jonathan, et al.
Publicado: (2014)

Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Improving Neurological Function: A Multicenter, Cluster-Randomized Trial (GIANT)
por: Zhang, Xuting, et al.
Publicado: (2021)

Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone: A MR CLEAN-NO IV substudy
por: van den Berg, Sophie A, et al.
Publicado: (2023)

Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke
por: Chalos, Vicky, et al.
Publicado: (2019)

Are EMS bypass policies effective implementation strategies for intravenous alteplase for stroke?
por: Harris, Alex H. S., et al.
Publicado: (2020)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Low versus standard dose intravenous alteplase in the treatment of acute ischemic stroke in Egyptian patients
por: Salem, Gelan M., et al.
Publicado: (2021)

Benefit and risk of intravenous alteplase in patients with acute large vessel occlusion stroke and low ASPECTS
por: Broocks, Gabriel, et al.
Publicado: (2023)

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Bolus-Infusion Delays of Alteplase during Thrombolysis in Acute Ischaemic Stroke and Functional Outcome at 3 Months
por: Acheampong, Paul, et al.
Publicado: (2014)

The Epidemiology of Neurological Complications in Adults With Sickle Cell Disease: A Retrospective Cohort Study
por: Maduakor, Chinedu, et al.
Publicado: (2021)

No sex difference was found in the safety and efficacy of intravenous alteplase before endovascular therapy
por: Fang, Min, et al.
Publicado: (2022)

Utility of current thrombophilia screening in young patients with stroke and TIA
por: Alakbarzade, Vafa, et al.
Publicado: (2018)

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
por: Tan, Ge, et al.
Publicado: (2017)

Impact of Intravenous Alteplase Door-to-Needle Times on 2-Year Mortality in Patients With Acute Ischemic Stroke
por: Bhatt, Nirav R., et al.
Publicado: (2021)

Effect of Intravenous Alteplase on Functional Outcome and Secondary Injury Volumes in Stroke Patients with Complete Endovascular Recanalization
por: Broocks, Gabriel, et al.
Publicado: (2022)

Effects of intravenous thrombolysis with alteplase combined with edaravone on cerebral hemodynamics and T lymphocyte level in patients with acute cerebral infarction
por: Li, Xiu-Xiu, et al.
Publicado: (2020)

Impact of Medical Community Model on Intravenous Alteplase Door-to-Needle Times and Prognosis of Patients With Acute Ischemic Stroke
por: Li, Hongfei, et al.
Publicado: (2022)

Predicting prognosis in patients with stroke treated with intravenous alteplase through the 24‐h trajectory of blood pressure changes
por: Fan, Kaiting, et al.
Publicado: (2021)

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022)

Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis
por: Huang, Pan, et al.
Publicado: (2023)

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Role of intravenous alteplase on late lesion growth and clinical outcome after stroke treatment
por: Konduri, Praneeta, et al.
Publicado: (2023)

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
por: Logallo, Nicola, et al.
Publicado: (2014)

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances
por: Alper, Brian Scott, et al.
Publicado: (2020)

Frontotemporal Dementia with Parkinsonism and Epilepsy Associated with VGKC Antibodies: Case Report and Literature Review
por: Saint, Matthew, et al.
Publicado: (2021)

Early neurological worsening in acute ischaemic stroke patients
por: Nacu, A., et al.
Publicado: (2015)

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China
por: Zheng, Huaguang, et al.
Publicado: (2020)

Safety and Efficacy of Intravenous Alteplase before Endovascular Thrombectomy: A Pooled Analysis with Focus on the Elderly
por: Honig, Asaf, et al.
Publicado: (2022)

Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours
por: Chen, Jigang, et al.
Publicado: (2023)

Predicting prognosis in patients with stroke treated with intravenous alteplase through blood pressure changes: A machine learning‐based approach
por: Fan, Kaiting, et al.
Publicado: (2023)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dr4of4bfu52h01qgt7ei9jortn